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To directly test the contribution of Scgb1a1+ Clara
cells to postnatal growth, homeostasis, and repair of
lung epithelium, we generated a Scgb1a1-CreERTM
‘‘knockin’’ mouse for lineage-tracing these cells.
Under all conditions tested, the majority of Clara cells
in the bronchioles both self-renews and generates
ciliated cells. In the trachea, Clara cells give rise to
ciliated cells but do not self-renew extensively.
Nevertheless, they can contribute to tracheal repair.
In the postnatal mouse lung, it has been proposed
that bronchioalveolar stem cells (BASCs) which
coexpress Scgb1a1 (Secretoglobin1a1) and SftpC
(Surfactant Protein C), contribute descendants to
both bronchioles and alveoli. The putative BASCs
were lineage labeled in our studies. However, we
find no evidence for the function of a special BASC
population during postnatal growth, adult homeo-
stasis, or repair. Rather, our results support a model
in which the trachea, bronchioles, and alveoli are
maintained by distinct populations of epithelial
progenitor cells.
INTRODUCTION
The lung consists of three anatomically distinct regions (trachea,
bronchioles, and alveoli), each with specialized roles in respira-
tion and host defense. Following postnatal growth, the lung rea-
ches a steady state in which epithelial turnover is low. However,
all regions can repair after injury. The identity of the resident stem
or progenitor cells responsible for lung postnatal growth,
homeostasis, and repair remains controversial (Kim, 2007; Neu-
ringer and Randell, 2006; Rawlins and Hogan, 2006). Here, we
exploit the classic technique of lineage tracing to address this
critical question.
The composition of the lung epithelium varies along the prox-
imal-distal axis. In the mouse, the tracheal epithelium is pseu-
dostratified and consists mainly of basal cells, secretory noncili-
ated cells (here called Clara cells for convenience), and ciliatedcells. In the interlobar airways (bronchioles), a mixture of Clara
and ciliated cells is interspersed with clusters of neuroendocrine
(NE) cells. The alveolar epithelium consists of type 2 and type 1
cells. There is compelling indirect evidence that following injury
to the mouse bronchioles, the Clara cells can both self-renew
and give rise to new ciliated cells (for example, Evans et al.,
1978 andReynolds et al., 2000b). However, it is not clear whether
all Clara cells, or only restricted subpopulations, have this
capacity. Following naphthalene injury, the only surviving Clara
cells are located near NE cells and at the bronchioalveolar
duct junction (BADJ); these survivors are both necessary and
sufficient to restore the epithelium (Giangreco et al., 2002;
Hong et al., 2001; Reynolds et al., 2000a). Another subset of
Clara cells has been identified, based on their location at the
BADJ and their coexpression of Scgb1a1 (Secretoglobin 1a1,
also known as CC10 or CCSP), a marker of Clara cells, and an
alveolar type 2 cell marker Surfactant protein C (SftpC, also
known as SpC). These cells proliferate following lung injury.
Based on their in vitro differentiation potential, it has been
proposed that they are bronchioalveolar stem cells (BASCs)
that give rise to both bronchiolar and alveolar cells in vivo (Kim
et al., 2005). However, their lineage fate has not been followed.
Moreover, there is considerable indirect evidence that type 2
cells are a major progenitor for the alveolar epithelium (Evans
et al., 1973, 1975). Many questions remain: does only a subset
of Clara cells behave as stem cells for airway maintenance
and/or repair, or do all, or most, Clara cells fulfill these functions?
Are there facultative progenitors that are only activated in
response to injury? How do the putative BASCs fit into these
models?
In the trachea, lineage-labeling studies have shown that after
Clara cell injury, basal cells are an important stem cell population
(Hong et al., 2004). However, in response to injury of ciliated
cells, only Clara cells, not basal cells, divide (Evans et al.,
1986). This raises the possibility that there are two separate pop-
ulations of stem cells in the trachea: basal and Clara cells. Alter-
natively, do basal cells function as a long-term, self-renewing
stem cell population and Clara cells as a transiently amplifying
(TA) population?
To address these questions, we have generated mice in which
the gene encoding a Cre Recombinase-modified Estrogen
Receptor fusionprotein (CreER) is ‘‘knocked into’’ theendogenousCell Stem Cell 4, 525–534, June 5, 2009 ª2009 Elsevier Inc. 525
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Clara Cells Are Long-Term Airway ProgenitorsScgb1a1 locus. Scgb1a1 is expressed in bronchiolar Clara cells,
including putative BASCs, and tracheal Clara cells. Using these
mice, we have lineage-labeled Clara cells and followed their
descendents during postnatal growth in the steady-state adult
and in response to several models of epithelial lung injury. Our
results do not support models in which either unlabeled cells or
highly spatially-restricted subpopulations of Scgb1a1+ cells
(such as BASCs) function as stem cells to maintain the postnatal
bronchioles. Nor do Scgb1a1+ cells contribute significantly to
the alveoli. Rather, our data suggest that in the bronchioles
many Scgb1a1+ cells function as long-term progenitors. By
contrast, in the trachea, most Clara cells are a TA population
derived from Scgb1a1 basal cells.
RESULTS
Characterization of Scgb1a1-CreERTM Mice
To generate Scgb1a1-CreERTM mice, we targeted CreERTM to
the 30 UTR of the endogenous Scgb1a1 locus (Figure S1A avail-
able online). Using this allele, we established conditions for
lineage-labeling both putative BASCs and Clara cells at different
developmental stages. In CreERTM/LoxP lineage-tracing
studies, recombination of the floxed reporter allele is dependent
on the doseof tamoxifen (tmx) andoccurs stochastically in a frac-
tion of the cells that express Cre (Hayashi and McMahon, 2002).
The level of Cre expression also affects recombination effi-
ciency. Adult Scgb1a1-CreERTM; Rosa26R-eYFP mice were
given one, two, three, or four injections of tmx every other day,
and their lungs were harvested 4 days after the final injection
(Figure 1A). As expected, recombination occurred in Scgb1a1+
cells throughout the bronchioles and trachea in a dose-depen-
dent manner (Figures 1B–1D). The proportion of labeled cells
varied by region and was always trachea < proximal bronchioles
< terminal bronchioles (data not shown). This is consistent with
published differences in the amount of Scgb1a1 protein per
cell between these regions (Dodge et al., 1993).
Lineage-labeled cells were identified by immunohistochem-
istry, location, and morphology (Table S1). A single dose of tmx
labeled Clara cells throughout the bronchioles, but few putative
BASCs. Two doses labeled 50% of bronchiolar Clara cells and
60% of BASCs. In addition, a few (1%) type 2 cells were also
labeled. Finally, four consecutive doses labeled 80% of bronchi-
olar Clara cells, more than 90%of BASCs, and 8%of type 2 cells
(summarized in Table 1).Many of the lineage-labeled type 2 cells,
in this and all subsequent experiments, are in the vicinity of
a BADJ. Estimates for cell turnover in the adult alveoli vary, but
most are >100 days (Kauffman, 1980). This makes it unlikely
that the labeled type 2 cells were derived from the bronchiolar
epithelium during the 11 days from the first tmx exposure526 Cell Stem Cell 4, 525–534, June 5, 2009 ª2009 Elsevier Inc.(Figure 1A). More likely, the lineage-labeled type 2 cells them-
selves express low levels of Scgb1a1 and hence, CreER. In
previous studies, low levels of Scgb1a1 protein were observed
in alveolar type 2 cells in the adult rabbit, and Scgb1a1 mRNA
has been detected in adult rat type 2 cells (Patton et al., 1991;
Strum et al., 1992). Moreover, rat Scgb1a1 promoter fragments
can drive gene expression in a subset of type 2 cells in transgenic
mice (Perl et al., 2005). We confirmed by immunohistochemistry
that some SftpC+ type 2 cells in the alveoli of adult mice contain
very low levels of Scgb1a1, located in cytoplasmic vesicles
(Figures 1E and 1F). These cells could be detected throughout
postnatal life, using multiple type 2 cell markers (Figure S2).
These data account for the lineage-labeling of some type 2 cells
and demonstrate that the putative BASCs are not unique in
coexpressing Scgb1a1 and SftpC.
To test for tmx-independent recombination of the reporter,
adult Scgb1a1-CreERTM; Rosa26R-eYFP mice were treated
with vehicle alone. Variable levels (5%) of recombination
Figure 1. Scgb1a1-CreERTM Mice Show Dose-Sensitive Activation
of Reporter Gene Expression in Response to Tamoxifen
(A) Time course of tmx injections. Every adult mouse was injected on day 0 so
11 days always elapsed between the first tmx injection and sacrifice.
(B–D) Scgb1a1-CreERTM; Rosa26R-eYFP adult lung sections. Green: anti-
GFP, lineage label. Red: anti-pro-SpC, type 2 cells. Blue: anti-Scgb1a1, Clara
cells. Note the increase in the number of lineage-labeled cells with increasing
tmx dose. Arrowheads indicate lineage-labeled putative BASCs (always
contiguous with bronchiolar epithelium). Arrows indicate lineage-labeled
type 2 cells. (C) One, (D) two, or (E) four tmx injections.
(E and F) Alveoli from a 12-month-old mouse. Green: anti-Scgb1a1. Red: anti-
pro-SpC. (F) Higher magnification of box in (E). Note that Scgb1a1 and pro-
SftpC are both present in many type 2 cells, in separate vesicles. Arrows
indicate (Scgb1a1+, SftpC+) type 2 cells. The level of Scgb1a1 protein in
type 2 cells is low and can only be detected by overexposing the bronchiolar
Scgb1a1 signal. Scale bars: 100 mm, (B)–(E); 160 mm, (F).Table 1. Summary of the Extent of Recombination in Scgb1a1+ Cell Populations when Scgb1a1-CreERTM; Rosa26R-eYFP Mice Are
Exposed to Varying Amounts of Tamoxifen
Time and Dose of tmx Tracheal Clara Cells Bronchiolar Clara Cells Putative BASCs Alveolar Type 2 Cells
E18.5 13 0.1 mg/g ++ ++ ++ +
Adult 23 0.25 mg/g ++ ++ ++ +
Adult 43 0.25 mg/g +++++ +++++ +++++ ++
Adult carrier control — + — —
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Clara Cells Are Long-Term Airway ProgenitorsFigure 2. Clara Cells Are a Self-Renewing
Progenitor for Postnatal Growth of the
Bronchioles, but Not the Trachea
(A–F) Scgb1a1-CreERTM; Rosa26R-LacZ. (G–L)
Scgb1a1-CreERTM; Rosa26R-eYFP. Embryos
were exposed to tmx at E18.5.
(A–F) Whole-mount lungs. (A) P2, (B and D) P3
weeks, and (C, E, and F) P52 weeks (1 year).
(G–I) Lung sections. Green: anti-GFP, lineage
label. Red: anti-pro-SpC, type 2 cells. Blue: anti-
Scgb1a1, Clara cells. Arrowheads indicate
lineage-labeled type 2 cells. Arrows indicate
lineage-labeled putative BASCs. (G) P2, (H) P3
weeks, and (I) P52 weeks. Inset in (H) shows
lineage labeled ciliated cells (arrowheads), but
not neuroendocrine cells (arrow). Green: anti-
GFP, lineage label. Red: anti-CGRP, neuroendo-
crine cells. Blue: anti-b-tubulin, ciliated cells.
(J–L) Trachea sections. Green: anti-GFP, lineage
label. Red: anti-b-tubulin, ciliated cells. Blue:
anti-Scgb1a1, Clara cells. Animals sacrificed at
(J) P2, (K) P3 weeks, or (L) P52 weeks (1 year).
(M and N) Graphs to show mean percentage
lineage-labeled Clara, ciliated, and type 2 cells
following tmx exposure at E18.5. Error bars show
SEM. (M) lung, (N) trachea. Scale bars: 2 mm,
(A); 1 mm, (B and C); 200 mm, (D–F); and 50 mm
(G–L).were observed at P12 weeks in bronchiolar Clara cells, but never
in tracheal Clara cells, putative BASCs, or type 2 cells (Table S2).
To lineage-label Scgb1a1+ cells during postnatal growth, we
administered a single dose of tmx to pregnant Scgb1a1-
CreERTM; Rosa26R-eYFP females on embryonic day (E) 18.5.
On postnatal day (P) 2, their offspring had recombined the
reporter in 50% of bronchiolar Clara cells, 70% of putative
BASCs, and a small subset (1%) of type 2 cells (Table S3).
During mouse development, Scgb1a1 protein is first detected
at low levels in the bronchioles at E15.5 and at higher levels at
E16.5 (Rawlins et al., 2007; Wuenschell et al., 1996). Consistent
with this, we were able to activate the reporter by injecting preg-
nant Scgb1a1-CreERTM; Rosa26R-LacZ females with tmx from
E14.5 onward, but not at earlier stages (Figures S3A–S3E).
When embryos were exposed to tmx at E14.5 and their lungs
were assessed at P2, small groups of lineage-labeled cells,
including both Clara and ciliated cells, were scattered
throughout the bronchioles (Figures S3C and S3D). If tmx was
administered at E16.5, the percentage of Clara cells labeling,
and the descendents they produced, were indistinguishable
from exposure at E18.5 (Figure S3F).
During Postnatal Growth, Scgb1a1+ Lineage-Labeled
Bronchiolar Cells Self-Renew and Give Rise to Ciliated
Cells
During the postnatal period, there is a significant increase in size
of the mouse lung. This includes increases in airway diameter
and length (Figures 2A–2C, note scale bars), and number of
alveoli (Randell et al., 1989). To lineage-trace Scgb1a1+ cells
during this period, we injected pregnant females once at E18.5
and sacrificed offspring at P2 days; 3 weeks; 3, 6, and 9 months;and 1 year. This period includes rapid postnatal growth followed
by slower growth and then steady-state maintenance of the lung
(Kauffman, 1980). We confirmed by BrdU labeling that prolifera-
tion of epithelial cells throughout the lung continues during the
entire experimental period (Figure S4).
To follow the lineage of Scgb1a1+ cells, the proportions of
labeled basal, Clara, ciliated, NE, putative BASCs, and type 2
cells were scored in sections of each lung after immunohisto-
chemistry and confocal microscopy (Table S1). Because the
extent of recombination varied within the organ, we were careful
to assess the same range of anatomical regions per lung. For
example, 3 proximal airways, 20 terminal bronchioles (including
BADJs), and 10 alveolar regions (distal from any visible BADJs)
were imaged and scored (see the Experimental Procedures).
In the bronchioles, the percentage of lineage-labeled Clara
cells and putative BASCs remained constant for 1 year (Figures
2G–2I and 2M; Table S3). Therefore, throughout this period, the
labeled and unlabeled Scgb1a1+ Clara cells self-renew at the
same rate. By contrast, the percentage of labeled ciliated cells
gradually increased from 0 at P2 to 25% between 3 weeks and
3 months and, subsequently, rose slightly (Figure 2H, inset,
and 2M). Lineage label was never observed in the NE cells or
in the mesenchymal or endothelial compartments (Figure 2H,
inset; Table S3). These data show that, overall, the Scgb1a1+
cell population in the bronchioles (Clara cells and putative
BASCs) both self-renews and gives rise to ciliated cells. In
whole-mount assays, the patches of labeled and unlabeled
bronchiolar cells are of roughly equal size and appear randomly
distributed throughout the airways (Figures 2A–2F). This
suggests that the ability to self-renew is widespread within the
total bronchiolar Scgb1a1+ cell population.Cell Stem Cell 4, 525–534, June 5, 2009 ª2009 Elsevier Inc. 527
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Clara Cells Are Long-Term Airway ProgenitorsLabeled Bronchiolar Scgb1a1+ Cells Do Not Contribute
to the Alveoli during Postnatal Growth
In the alveoli, 1% of type 2 cells were initially labeled by giving
tmx at E18.5 (Figures 2G and 2M; Table S3). If alveolar type 2
cells are a self-renewing population in which many cells have
equivalent progenitor potential, we would expect the percentage
of lineage-labeled type 2 cells to remain steady throughout the
experiment. Alternatively, if (Scgb1a1+, SftpC+) cells, either the
lineage-labeled type 2 cells or the putative BASCs, are acting
as stem cells, the proportion of lineage-labeled type 2 cells
would increase over time, as these cells would contribute more
descendents to the alveoli than unlabeled type 2 cells. The
labeling of type 2 cells varied between 1% and 5% over 1 year
(Figures 2G–2I and 2M; Table S3). This suggests that the
lineage-labeled (Scgb1a1+, SftpC+) type 2 cells do not self-
renew or produce new type 2 cells at a significantly greater
rate than the unlabeled type 2 cell population. Moreover, the
results are not consistent with the bronchiolar Scgb1a1+ cells
(either Clara cells or putative BASCs) contributing to the growth
and maintenance of the alveoli. In support of these conclusions,
using confocal reconstruction, we did not observe lines, or
patches, of lineage-labeled alveolar cells appearing over time
in proximity to the BADJs. This might have been expected if
cells in the bronchioles are contributing substantial numbers
of descendents to the alveoli. This result was confirmed by
exposing Scgb1a1-CreERTM; Rosa26R-LacZ embryos to tmx
at E18.5 and examining lungs by whole-mount X-gal staining
at P2 days, 3 weeks, 6 months, and 1 year (n = 3 lungs
each time). At all times, these lungs displayed a distinct
boundary between the bronchioles, which contained a large
number of lineage-labeled cells, and the alveoli which con-
tained only a few LacZ+ cells (Figures 2A–2C and 2F). In the
older lungs, P3 weeks and beyond, a small number (not quan-
titated) of labeled type 1 cells were observed (data not shown).
This is consistent with the labeled type 2 cells generating type 1
cells over time (Adamson and Bowden, 1975; Kauffman et al.,
1974).
In conclusion, we have found no evidence for any significant
contribution of descendents of Scgb1a1+ bronchiolar cells (Clara
cells or putative BASCs) to the alveoli during normal postnatal
growth and for up to 1 year. This is the case even though many
new alveoli are formed in early postnatal life (Randell et al.,
1989), and there is proliferation of cells throughout the period
as judged by BrdU labeling (Figure S4).
Bronchiolar Scgb1a1+ Cells in the Steady-State Adult
Lung
We next investigated the lineage fate of Scgb1a1+ cells in the
steady-state adult. Adult Scgb1a1-CreERTM; Rosa26R-eYFP
mice were given four injections of tmx. This labeled 80% of Clara
cells, 90% of putative BASCs, and 8% of type 2 cells (Table S4).
Lungs were harvested over a 1 year period and scored as before.
Widespread proliferation was detected in adult mice by BrdU
incorporation (Figure S4), confirming that epithelial cell turnover
continues throughout this period.
In the bronchioles, the percentage of lineage-labeled Clara
cells and putative BASCs remained constant during the experi-
ment. By contrast, the percentage of lineage-labeled ciliated
cells increased 40-fold (Figures 3A–3C, 3G, and 3J; Table S4).528 Cell Stem Cell 4, 525–534, June 5, 2009 ª2009 Elsevier Inc.This result is consistent with the Clara cells both self-renewing
and giving rise to new ciliated cells. If we assume that all new cili-
ated cells are derived from Clara cells, the rate of ciliated cell
replacement estimated from these data is 0.9% per week. This
is consistent with our previous independent estimate of 0.7%
ciliated cell turnover per week (Rawlins and Hogan, 2008),
supporting the hypothesis that all new ciliated cells in the adult
bronchioles are derived from Clara cells.
The percentage of lineage-labeled type 2 cells in the adult al-
veoli did not increase consistently throughout the experiment.
This suggests that (Scgb1a1+, SftpC+) cells, either lineage-
labeled type 2 cells or putative BASCs, do not self-renew or
generate new type 2 cells at a different rate to the SftpC+ type
2 cell population. It also supports the idea that bronchiolar
Scgb1a1+ cells are not contributing descendents to the alveoli
at steady state. Alveolar epithelial cell turnover has been postu-
lated to be very slow (Kauffman, 1980). However, after the 1 year
chase period, we observed lineage-labeled type 1 cells, presum-
ably derived from the initial population of labeled type 2 cells
(Figure 3C, marked by an asterisk). These data suggest that turn-
over of the alveoli did occur.
Finally, we exposed animals to two, rather than four, tmx
injections to label a smaller proportion of Clara cells, putative
BASCs, and very few type 2 cells (Figures 3E and 3F; Table S5).
Similar patterns of cell behavior were also seen in these mice
(Table S5).
The Response of Bronchiolar Scgb1a1+ Cells to Injury
We now address the question of how Scgb1a1+ cells contribute
to the repair of the lung in three different injury models: exposure
of adults to naphthalene and exposure of adults and neonates to
hyperoxia. Following naphthalene injury to Scgb1a1-CreERTM;
Rosa26R-LacZ mice, we observed small numbers of surviving
lineage-labeled cells (Figure S5A and S5B). After 3 weeks, large
patches of airway epithelium, including both Clara and ciliated
cells, were lineage labeled (Figure S5C–S5E). This confirms
previous reports that surviving Scgb1a1+ cells can divide and
regenerate the airway epithelium following naphthalene injury
(Giangreco et al., 2002; Hong et al., 2001; Reynolds et al.,
2000a). This result also demonstrates that the Scgb1a1-
CreERTM allele is active in naphthalene-resistant Clara cells.
Adult hyperoxia was used to test the ability of bronchiolar
Scgb1a1+ cells, including putative BASCs, to contribute to the
alveoli following injury. We exposed adult Scgb1a1-CreERTM;
Rosa26R males, which had received different doses of tmx, to
>99% oxygen (O2) for 54 or 60 hr, followed by recovery in 30%
O2 for 12 hr and 2 to 3 weeks in room air. Consistent with
previous reports, there were focal regions of severe damage
and inflammation throughout the alveoli and terminal bronchi-
oles following O2 exposure (Figure 4A) (Crapo, 1986; Tryka
et al., 1986). Moreover, 48–72 hr following exposure, there was
widespread BrdU uptake and Ki67 expression in cells
throughout the alveoli and the terminal bronchioles, including
cells located at the BADJ (Figures 4B and 4C).
To distinguish between the relative contributions of bronchi-
olar or alveolar lineage-labeled cells to alveolar repair, two regi-
mens of tmx exposure were employed. In the first two experi-
ments, mice were given 4 or 5 tmx injections to label Clara
cells, putative BASCs, and some type 2 cells. In the second
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Clara Cells Are Long-Term Airway Progenitorstwo experiments, mice were given 1 or 2 tmx injections to label
Clara cells, 50%–60% of putative BASCs, and only a very few
(<1%) type 2 cells. Following hyperoxia and recovery, the lungs
were assessed in two ways. First, we asked if lineage-labeled
bronchiolar cells had contributed any descendents to the
alveolar compartment. To do this quantitatively, we scored
100–300 alveolar regions from control and recovered groups of
mice for the presence/absence of alveolar lineage labeling. We
positioned a squarewith one edge intersecting the terminal bron-
chiole 5 or 6 cell diameters from the BADJ (diagram in Figure 4D)
and scored for the presence/absence of alveolar lineage labeling
within the square. The position of the square ensured that the
alveolar type 2 cells immediately adjacent to the terminal bron-
chioles were included. If lineage-labeled cells in the bronchioles
were contributing descendents to the alveoli, then following
injury and repair, more of the squares would score as ‘‘present’’
for lineage-labeled alveolar cells. This was not observed in any of
the four experiments (Figure 4H; Table S6). Rather, in experi-
ments 1 and 2 (where the proportion of lineage-labeled type 2
cells was originally highest), the proportion of BADJs that scored
positive actually decreased (statistically significant, p = 0.008
and 0.0003). This suggests that when lineage-labeled type 2
cells were killed by O2 exposure, they were not replaced by
lineage-labeled cells from the bronchioles. Second, we asked if
Figure 3. Clara Cells Are a Self-Renewing
Progenitor in the Adult Steady-State Bron-
chioles, but Not the Trachea
(A–I) Adult Scgb1a1-CreERTM; Rosa26R-eYFP
mice injected twice (E–G) or four times (A–D, H,
and I) with tmx or vehicle. (A–F) Lung sections.
Green: anti-GFP, lineage label. Red: anti-pro-
SpC, type 2 cells. Blue: anti-Scgb1a1, Clara cells.
Arrowheads indicate lineage-labeled type 2 cells.
Arrows indicate lineage-labeled putative BASCs.
(A–C) 43 tmx followed by (A) 4 days, (B) 24 weeks
(6 months), or (C) 52 weeks (1 year) chase. Aster-
isks (*) indicate lineage-labeled type 1 cells. (D)
Control plus 4 days chase. (E and F) 23 tmx fol-
lowed by (E) 4 days or (F) 52 weeks chase. (G)
Bronchiolar section, 23 tmx followed by 52 week
chase. Green: anti-GFP, lineage label. Red: anti-
CGRP, neuroendocrine cells. Blue: anti-b-tubulin,
ciliated cells. Arrowheads indicate lineage-labeled
ciliated cells. Neuroendocrine cells are not lineage
labeled. (H and I) Tracheal sections. Green: anti-
GFP, lineage label. Red: anti-Scgb1a1, Clara cells.
Blue: anti-T1a, basal cells. 43 tmx followed by (H)
4 days or (I) 52 weeks chase.
(J and K) Graphs to show mean percentage
lineage-labeled Clara, ciliated, and type 2 cells
following 43 adult tmx injections. Error bars
show SEM. (J) lung, (K) trachea. Scale bars are
all 50 mm.
any lineage-labeled type 1 cells had
been generated by the repair process.
Lineage-labeled type 1 cells were
observed in animals that had received 4
or 5 tmx injections and, therefore, had
labeled type 2 cells. However, none
were seen in the animals without significant type 2 cell labeling,
even though there were abundant labeled cells in the BADJ
(Figures 4D–4G). Therefore, we have been unable to find
evidence for Scgb1a1+ bronchiolar cells (Clara cells or putative
BASCs) contributing to the alveoli during repair. Rather, our
results suggest that following O2 injury, new type 1 cells are
produced from type 2 cells, consistent with previous reports
(Evans et al., 1975).
We also tested the response of Scgb1a1+ cells to alveolar
injury during neonatal growth, when the cells might be expected
to have higher reparative potential. We exposed Scgb1a1-
CreERTM; Rosa26R-eYFP litters to tmx at E18.5 and then to
>95% O2 from P0 to P7. This was followed by 3 days recovery
in 60% O2 and 4–10 days in room air. Consistent with previous
reports (Ahmed et al., 2003), we observed alveolar simplification
and an increase in cell proliferation, asmeasured byKi67 expres-
sion, in treated animals comparedwith controls (Figure S6). Alve-
olar regions adjacent to BADJs were scored in sections for the
presence or absence of lineage-labeled cells as before. No
difference in the percentage of alveolar regions containing
lineage-labeled cells was observed between control and
O2-exposed mice (Figure S6; Table S7). Therefore, bronchiolar
Scgb1a1+ cells did not contribute to alveolar repair during
postnatal development.Cell Stem Cell 4, 525–534, June 5, 2009 ª2009 Elsevier Inc. 529
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Clara Cells Are Long-Term Airway ProgenitorsTracheal Scgb1a1+ Cells during Postnatal Growth
and Adult Homeostasis
The behavior of lineage-labeled Scgb1a1+ cells in the trachea
during postnatal growth was different from that seen in the
bronchioles. In the trachea, the percentage of lineage labeling
of Scgb1a1+cells showeda significantdecreaseover time, rather
than remaining constant (Figures 2J–2L and 2N; Table S3).
Figure 4. Scgb1a1+ Bronchiolar Cells, Including Putative BASCs, Do
Not Contribute to the Alveolar Compartment following O2-Induced
Alveolar Injury
Adult wild-type C57Bl/6 (A–C) or Scgb1a1-CreERTM; Rosa26R-eYFP (D–G)
lung sections. (A) 48 hr post-O2, hemotoxylin and eosin. Note extensive inflam-
matory cells around BADJ and terminal bronchioles, consistent with injury and
repair.
(B and C) Black: anti-BrdU, S phase cells. (B) Control, 48 hr post-room air, (C)
48 hr post-O2. Note extensive proliferation in terminal bronchioles and alveoli.
(D–G) Green: anti-GFP, lineage label. Red: anti-pro-SpC, type 2 cells. Arrow-
heads indicate lineage-labeled type 2 cells. Arrows indicate lineage-labeled
type 1 cells. (D and E) 43 tmx. (D) Control, room air plus 3 weeks recovery.
(Dotted box represents the alveolar area around each BADJ scored for pres-
ence/absence of lineage-labeled cells in H.) (E) 56 hr O2 plus 3weeks recovery.
Inset shows lineage-labeled type 1 cells at higher magnification. (F and G) 23
tmx. (F) Control, room air plus 3 weeks recovery. (G) 56 hr O2 plus 3 weeks
recovery. No lineage-labeled type 1 cells were found.
(H) Bar graph showing percentage of alveolar regions adjacent to a BADJ
which contain lineage-labeled cells in control (blue bars) and recovered (red
bars) animals in four independent O2 experiments. Error bars show SEM.
Means in experiments 1 and 2 are statistically different in a two-tailed t test.
Scale bars: 500 mm, (A)–(C); 1 mm, (D)–(G).530 Cell Stem Cell 4, 525–534, June 5, 2009 ª2009 Elsevier Inc.Therefore, in the trachea, the majority of Clara cells are not
long-term self-renewing progenitors, but are replenished by
descendents of an unlabeled cell population. The percentage of
lineage-labeled tracheal ciliated cells initially increased, showing
that tracheal Clara cells can give rise to ciliated cells. However,
the level of lineage labeling was not maintained in the ciliated
cell population, a result again consistent with an unlabeled cell
population acting as the major progenitor (Figure 2N; Table S3).
The lineage label was never observed in the basal cells (Table
S3). Similar results were obtained in the adult trachea at steady-
state (Figure 3H, 3I, and 3K; Tables S4 and S5). These data are
also consistent with an unlabeled cell population acting as the
major epithelial progenitor in the steady-state adult trachea.
The Response of Scgb1a1+ Cells to Tracheal Injury
We tested theability of Scgb1a1+Clara cells to repair the trachea.
Adult Scgb1a1-CreERTM; Rosa26R males were given four tmx
injections and then exposed to sulfur dioxide (SO2) to damage
the tracheal epithelium. In response to SO2, many tracheal
epithelial cells slough off, leaving cuboidal survivors tightly
adherent to the basement membrane (Rawlins et al., 2007).
Animals were sacrificed at the peak of epithelial cell proliferation,
24 hr post-SO2, or after epithelial recovery, 2 weeks post-SO2.
Analysis of whole-mount trachea showed that the number of
lineage-labeled cells surviving the injury was variable (Figures
5A–5C). However, in repaired tracheas, clusters of lineage-
labeled cells were observed, suggesting that survivingClara cells
can proliferate (Figures 5D and 5E). We confirmed this by
exposing injured mice to BrdU to label S phase cells (Figures
5F and 5G). Surviving lineage-labeled cells incorporated BrdU,
suggesting that they entered the cell cycle (28 ± 1.8%X-gal+ cells
colabeled with BrdU, n = 5 mice, 561 X-gal+ cells). However, the
X-gal+ cells were only a small fraction of the total BrdU+ epithelial
population (6.3 ± 2.6% BrdU+ cells colabeled with X-gal, n = 5
mice, 2304 BrdU+ cells). Thus, where Clara cells survive, they
can proliferate to contribute to tracheal repair. However, Clara
cells do not form the bulk of the proliferating population.
Clusters of lineage-labeled cells, consisting of both Clara and
ciliated cells, were larger following repair than in control mice
(Figures 5H and 5I). This suggests that tracheal Clara cells prolif-
erate at a greater rate following injury than at steady state. More-
over, a greater proportion of ciliated cells were lineage labeled
following injury. In control animals, 7.3 ± 3.6% ciliated cells
were lineage labeled 3 weeks following the final tmx injection
(n = 4 mice, 1392 ciliated cells), compared with 18.1 ± 3.2%
lineage-labeled ciliated cells following repair (n = 10 mice,
4364 ciliated cells). We used T1-alpha antibody staining to
detect basal cells (Farr et al., 1992). Very rare lineage-labeled
basal cells were observed following repair (0.34 ± 0.09%-labeled
basal cells, n = 6 mice, 2457 T1a+ cells), but never in control
animals (0 ± 0%-labeled basal cells n = 3 mice, 1102 T1a+ cells)
(Figure 5J, arrow marks lineage-labeled basal cell). Therefore,
injury changes the proportion of different cell types that dividing
tracheal Clara cells give rise to.
Single Cell Labeling of Scgb1a1+ Cells
Our results suggest that Clara cells are not a long-term self-
renewing progenitor in the trachea. However, tracheal Clara cells
can give rise to ciliated cells and do self-renew in response to
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Clara Cells Are Long-Term Airway ProgenitorsFigure 5. Tracheal Clara Cells Have Greater
Proliferative and Differentiative Potential
following Injury Than at Steady-State
(A–I) Scgb1a1-CreERTM; Rosa26R-LacZ trachea,
43 tmx. Blue: X-gal staining, lineage label.
(A–E) Ventral half of bisected whole-mount
trachea. (A) No injury control. (B and C) 24 hr
post-SO2 showing variable levels of Clara cell
survival. (D and E) 2 weeks post-SO2. (F–I)
Tracheal sections. (F and G) 24 hr post-SO2.
Black: anti-BrdU S-phase cells. (F) Surviving
lineage-labeled Clara cells can enter the cell
cycle. (G) The majority of proliferating cells are
not lineage labeled. (H and I) Brown: anti-
b-tubulin, ciliated cells. (H) Control plus 2 weeks.
Lineage-labeled cells are in small groups. (I) Two
weeks post-SO2. Large patches of lineage-
labeled cells, including both ciliated and Clara
cells, are present.
(J and J0) Scgb1a1-CreERTM; Rosa26R-CAG-
fGFP tracheal sections 2 weeks post-SO2.
Green: anti-GFP, lineage label. Red: anti-T1a,
basal cells. Two optical sections from a confocal
Z stack are shown. Arrow indicates lineage-
labeled basal cell in which colocalization of the
membrane-associated lineage label and membrane-associated T1a is visible in every optical section. Arrowheads indicate basal cells which appear to be
lineage-labeled in some optical sections only; these were scored as not lineage labeled. Scale bars: 0.5 mm, (A); 20 mm, (F–J).injury. We asked whether tracheal Clara cells can self-renew
during postnatal growth or if they only give rise to ciliated cells.
If they self-renew, they would be considered to be TA progeni-
tors. To answer this question, we lineage-labeled mostly single
tracheal Clara cells by exposing E18.5 Scgb1a1-CreERTM;
Rosa26R-eYFP embryos to a low dose of tmx. Clone size and
cellular composition were assessed in whole-mount prepara-
tions at P2 days and 3 weeks (n = 6 trachea each time) (Figures
6A and 6B). At P2 days, 70% of clones consisted of single-
labeled cells. By P3 weeks, 82% of clones consisted of more
than one cell, and 43% had four or more cells (Figure 6E). It
has been demonstrated that airway ciliated cells do not divide
(Evans et al., 1978; Rawlins and Hogan, 2008; Rawlins et al.,
2007). The observed increase in clone size can only have re-
sulted from the self-renewal of tracheal Clara cells. The overall
cellular composition of the clones also changed during the
experiment. At P2 days, 93%of clones consistedmostly of Clara
cells (expressed as the ratio of Clara: ciliated cells within the
clone, Figure 6G). By contrast, at P3 weeks, only 26% of clones
were mostly Clara cells. These data are consistent with the idea
that during postnatal growth, tracheal Clara cells can self-renew
to a limited extent and also give rise to ciliated cells, indicating
that they are a TA population.
Individual Clara cells in the bronchioles were also observed to
self-renew. At P2 days, 75% of bronchiolar clones were single
cells (Figures 6C and 6F). By P3 weeks, 73% of clones consisted
of at least two cells and 41% had four or more cells (Figures 6D
and 6F). However, clone composition differed between the
trachea and bronchioles. At P2 days, 98% of bronchiolar clones
consisted mostly of Clara cells. By P3 weeks, 88% of clones still
consisted mostly of Clara cells, even though clone size had
increased (Figures 6F and 6H). Therefore, during postnatal
growth, labeled Clara cells in the bronchioles have a greater
tendency to self-renew than to make ciliated cells.DISCUSSION
Our results support a model in which Scgb1a1+ cells in different
regions of the lung differ in their role as progenitors in vivo. In the
bronchioles, Scgb1a1+ cells can both self-renew and generate
ciliated cells during postnatal growth and adult homeostasis.
Importantly, however, they do not make a significant contribu-
tion of descendents to the alveoli under the conditions tested.
By contrast, in the trachea, the majority of Scgb1a1+ Clara cells
constitute a TA population during postnatal growth and steady
state, and their capacity for self-renewal and multilineage differ-
entiation increases in response to injury.
In the bronchioles, our data demonstrate that during postnatal
growth and homeostasis, the Scgb1a1+ Clara cells both self-
renew and give rise to ciliated cells for up to 1 year. Thus, the
overall behavior of the Clara cell population in the bronchioles
justifies their classification as stem cells, even though they are
not undifferentiated (Figures 2 and 3). Moreover, patch size in
whole-mount preparations (Figures 2 and 6) suggests that these
characteristics arewidely distributedwithin the bronchiolar Clara
cell population. Interestingly, our data also indicate that, within
the bronchioles, there are subpopulations of Clara cells that
differ in their ability to contribute to the ciliated cell population.
In the adult lineage-labeling experiments, the percentage of
labeled ciliated cells rose steadily. By contrast, in our postnatal
experiments, lineage labeling of the ciliated cells plateaued in
the adult (contrast Figure 3J with Figure 2M). This difference
cannot be attributed to the lower percentage of Clara cells, or
putative BASCs, labeled in the postnatal experiments. Lineage
labeling the same lower percentage in the adult also resulted in
a steady increase in ciliated cell labeling (Table S5). Conse-
quently, we hypothesize that the bronchioles contain subpopula-
tions of Clara cells differing in their ability to give rise to ciliated
cells. Specifically, our data suggest that a population is labeledCell Stem Cell 4, 525–534, June 5, 2009 ª2009 Elsevier Inc. 531
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Clara Cells Are Long-Term Airway Progenitorsin the adult, which is more able to give rise to ciliated cells than
the Clara cells labeled at E18.5. New experimental tools will be
required to investigate how these populations correlate with
the already-identified subpopulations of Clara cells, such as
the naphthalene-resistant fraction.
By contrast to their behavior in the bronchioles, we have
demonstrated that, in the trachea, the majority of Scgb1a1+
Clara cells behave as a TA population and are renewed from
an unlabeled progenitor (Figures 2, 3, 5, and 6). In a separate
set of experiments, we have lineage-labeled tracheal basal cells
and demonstrated that these cells both self-renew over a long
period and give rise to Clara and ciliated cells. Therefore, consis-
tent with previously published data, we conclude that tracheal
basal cells are a long-term self-renewing stem cell population
and tracheal Clara cells are TA progenitors. However, we cannot
exclude the possibility that there is a small population of long-
term self-renewing Clara cells in the trachea, as the lineage label
is maintained in a small percentage of tracheal Clara cells for up
to 1 year (Figures 2N and 3K). Following tracheal injury, the Clara
cells show increased capacity to both proliferate and self-renew.
Moreover, under this condition, they are capable of contributing
Figure 6. Scgb1a1+ Cells Proliferate during Postnatal
Growth of Both the Bronchioles and the Trachea
(A–D) Scgb1a1-CreERTM; Rosa26R-eYFP whole-mount lungs
exposed to 2.5 mg/gram tmx at E18.5. Green: anti-GFP, lineage
label. Red: anti-Scgb1a1, Clara cells. Blue: anti-acetylated
tubulin, ciliated cells. (A and B) Trachea (A) P2 or (B) P3 weeks.
(C and D) Bronchioles (C) P2 or (D) P3 weeks.
(E and F) Bar graphs showing percentage of different sized clones
at P2 (blue bars) and P3 weeks (red bars). (E) trachea; (F), bronchi-
oles.
(G and H) Bar graphs showing cellular composition of the lineage-
labeled clones at P2 and P3 weeks. Blue, ratio of Clara: ciliated
cells % 1, clones consist mostly of ciliated cells. Red, ratio of
Clara: ciliated cells > 1, clones consist mostly of Clara cells. (G),
trachea; (H), bronchioles. Scale bars all 100 mm.
rare descendents to the basal cell lineage (Figure 5J).
This result is consistent with previous observations
that mouse tracheal secretory cells can regenerate
the entire epithelium, including basal cells, in a xeno-
graft model (Liu et al., 1994). We speculate that in
response to severe depletion of basal cells, the TA
Clara cells can give rise to basal stem cells. This would
be analogous to the behavior of TA cells in the mouse
testis and Drosophila ovaries in response to stem cell
loss (Kai and Spradling, 2004; Nakagawa et al., 2007).
We showed that the putative BASC population
located at the BADJ is not unique in coexpressing
Scgb1a1 andSftpC. Rather, a proportion of type 2 cells
throughout thealveoli express low levelsofScgb1a1, as
well as high levels of SftpC in cytoplasmic vesicles
(Figures 1E and 1F; Figure S2). These cells can be
lineage labeled with high doses of tmx, especially in
the vicinity of the BADJ. Lineage analysis shows that
these cells can give rise to type 1 cells, but they do
not have a higher potential to generate type 2 cells
than the overall type 2 cell population (Figures 2, 4,
and 5). This strongly suggests, consistent with previ-
ouslypublisheddata, that type2cells (regardlessof theirScgb1a1
expression status) are themajor alveolar stem or progenitor cells.
Furthermore, we have been unable to find any evidence that
Scgb1a1+ bronchiolar cells (Clara cells or putative BASCs)
contributesignificantnumbersofdescendents to thealveoli under
anyof thephysiologically-relevant conditions tested (Figures2–4).
These results are in contrast to previous publications that sug-
gested, based on in vitro data, that the putative BASCs are
a stem cell for both the bronchioles and alveoli (Kim, 2007; Kim
et al., 2005). It is still possible that the large scale destruction of
type 2 cells or some other extreme injury would reveal a latent
potential of bronchiolar Scgb1a1+ cells to contribute to thealveoli.
Currently we do not understand the significance of the fact that
some Scgb1a1+ bronchiolar Clara cells express SftpC and,
conversely, that some alveolar type 2 cells express Scgb1a1.
There is accumulating evidence that the (Scgb1a1+, SftpC+)
coexpressing cell population increases in number in mouse
models of lung cancer (Ventura et al., 2007; Yang et al., 2008).
However, it is not clear if this is due to preferential proliferation
of pre-existing (Scgb1a1+, SftpC+) cells or to upregulation of
SftpC or Scgb1a1 in response to oncogenic activation. It532 Cell Stem Cell 4, 525–534, June 5, 2009 ª2009 Elsevier Inc.
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contribute significantly to some lung pathologies.
Our data demonstrate that the range of epithelial cells that
function as stem or long-term self-renewing progenitor cells in
the lungs is greater than previously thought. This has implica-
tions for studies of human lungs in which BASCs have yet to
be identified. Moreover, our data showing that the different cell
lineages produced by progenitor cells in the trachea can be
altered in response to local conditions is highly relevant to
studies on pathogenic epithelial remodeling and regenerative
medicine. It will be important in the future to understand the
molecular mechanisms that determine progenitor cell self-
renewal and lineage allocation in the lung and how these are
modulated during repair.
EXPERIMENTAL PROCEDURES
Mouse Strains
9.3 Kb of the 129/SvEv Scgb1a1 locus was cloned into pBS-KS upstream of
a diptheria toxin cassette. An IRESCreERTM-floxed-PGK-Neo cassette (kindly
provided by Mario Capecchi) was cloned into an Asc1 site in the 30UTR. The
linearized construct was electroporated into 129/SvEv ESCs. Southern blot
confirmed correct targeting of multiple ESC lines, and one was used to
generate chimeras by blastocyst injection. Scgb1a1-CreERTM mice were
crossed with FLPeR mice (Farley et al., 2000) to remove the Neo cassette
and then backcrossed to C57Bl/6. All experiments were performed at the N2
or N3 backcross generation. Adult mice were 8–12 weeks old. Between two
and five animals were used at each time point in every experiment. Rosa26R-
LacZ (Gt(Rosa)26Sortm1Sor), Rosa26R-eYFP (Gt(Rosa)26Sortm1(eYFP)Cos), and
Rosa26R-CAG-fGFPmicewere used at the N3C57Bl/6 backcross generation.
The Rosa26R-CAG-fGFP allele is described in Figure S1.
Tamoxifen Administration
A 20 mg/ml tmx stock solution was dissolved in Mazola corn oil. Unless other-
wise stated, Scgb1a1-CreERTM; Rosa26R adults were injected intraperitone-
ally with 0.25 mg per gram body weight tmx every other day up to five times.
Pregnant females were given a single intraperitoneal injection of 0.1 mg or,
for low-dose experiments, 2.5 mg tmx per gram body weight. For adult injury
experiments, the final tmx injection was administered 1 week (SO2 and naph-
thalene) or 2 weeks (O2) before injury.
Airway Injury
Neonatal Oxygen Exposure
Scgb1a1-CreERTM/+ females were mated with homozygous Rosa26ReYFP
males. Matched pairs of pregnant females were injected with 0.1 mg/gram
body weight tmx at E18.5. After birth, the litter was exposed to >95% O2 or
air for 7 days (as described in Ahmed et al., 2003). At P7, litters were switched
to 60% O2 for 3 days, followed by 4–10 days in room air. Two independent
experiments were performed.
Adult Oxygen Exposure
AdultmaleScgb1a1-CreERTM;Rosa26Rmice received 1–5 tmx injections. Two
weeks later, theywere randomly divided into control and hyperoxic groups. The
latterwereexposedcontinuously to>99%O2 (flow rate of 10 l/min, CO2<0.1%)
in polystyrene chambers for 54 or 60 hr, then to 30%O2 for 12 hr, as described
previously (Whitehead et al., 2006). Recovery was for up to 3 weeks. To deter-
mine the extent of injury, three animals were sacrificed 48 or 72 hr after the start
of the recovery period. Four independent experiments were performed.
Naphthalene Exposure
Adult male and female Scgb1a1-CreERTM; Rosa26R-LacZmice were injected
i.p. with 250 mg/Kg naphthalene (Sigma) dissolved in Mazola corn oil. Animals
were sacrificed 72 hr or 3 weeks following naphthalene exposure.
SO2 Exposure
Adult males were placed in individual compartments of a polystyrene chamber
and exposed to 500 ppm SO2 in air for 3 hours. Recovery was for 2 weeks
(Rawlins et al., 2007). Three independent experiments were performed.BrdU Exposure
To detect cell proliferation in response to injury, mice were injected i.p. with
10 ml per gram body weight of a solution containing 3 mg/ml BrdU (Amersham
Biosciences) 1 hour (SO2) or 2 hours (O2) before sacrifice.
Immunohistochemistry and X-Gal Staining
Lungs were inflated with up to 1 ml 4% paraformaldehyde (PFA) and fixed 4 hr
(P3 weeks and older) or 1 to 2 hr (P2 to P20) at 4C in 4% PFA. For immuno-
histochemistry, lungs were washed in PBS and either sucrose-protected,
embedded in OCT (Optimum Cutting Temperature Compound, Tissue-Tek),
and sectioned at 12 mmor permeabilized in 0.3%Triton X-100 for whole-mount
staining. Primary antibodies were rat anti-GFP (1:500, Nacalai Tesque, 04404-
84), chick anti-GFP (1:500, Aveslab, GFP1020), goat anti-Scgb1a1 (1:10000,
kindly provided by Barry Stripp), rabbit anti-Scgb1a1 (1:5000, Barry Stripp),
rabbit anti-SftpC (1:200, Chemicon, AB3428), mouse anti-b-tubulin (1:1000,
BioGenex, MU178-UC), mouse anti-Acetylated-tubulin (1:3000, Sigma,
T7451), rabbit anti-CGRP (1:500, Penninsular labs, IHC6006), hamster anti-
T1a (1:1000, Developmental Studies Hybridoma Bank, Clone 8.1.1.), and
mouse anti-Ki67 (1:100, Vector Labs, VP-K452). Alexa-Fluor-coupled
secondary antibodies (Invitrogen) were used at 1:500 dilution. For BrdU stain-
ing (mouse anti-BrdU, 1:500, Sigma, BU33, or rat anti-BrdU, 1:500, Accurate
Chemical Corporation, OBT0030) lungs were paraffin-sectioned and treated
as described (see Rawlins et al., 2007). To detect b-galactosidase activity,
whole lungs were stained in X-gal staining solution and then processed for
paraffin embedding.
Confocal Microscopy and Cell Counting
All images used for scoring cells consisted of a Z stack of optical sections
captured on a Leica Sp2 laser scanning confocal microscope. Multiple optical
sections, captured across the entire 12 mm thickness of the tissue section or
the entire apical-basal height of the epithelium in whole-mount preparations,
were scored to clearly distinguish cell boundaries. Cell identities were as-
signed using the criteria in Table S1. Images were always captured from the
same regions of each lung. In the tracheal sections, cells along the entire prox-
imal-distal axis of a sagittal section cut from the middle of the trachea were
scored in all experiments. Bronchiolar ciliated and NE cells were scored
from 8 proximal airway images and 2 terminal bronchioles per lung. Bronchi-
olar Clara cells and alveolar type 2 cells were scored from 20 terminal bronchi-
oles (including BADJs), 3 more proximal airways, and 10 alveolar regions
(distal from any visible BADJs) per lung.
Statistical Analysis
All results are reported as mean ± standard error of the mean. All error bars on
graphs represent standard error of the mean. Statistical tests are two-tailed t
tests.
SUPPLEMENTAL DATA
The Supplemental Data include six figures and seven tables and can be found
with this article online at http://www.cell.com/cell-stem-cell/supplemental/
S1934-5909(09)00156-8.
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